how does tirzepatide treat sleep apnea Mounjaro Drug Could Apnea, Study Finds In a prespecified secondary analysis
Description
El inyectable tirzepatida se distingue por su mecanismo de accin dual, ya que, activa los receptores del GIP ( Pptido insulinotrpico dependiente de glucosa ) y del GLP-1 ( Pptido similar a glucagn tipo-1 ), lo que contribuye a un mayor descenso de peso
A reasonable monitoring schedule might be: baseline labs before starting, repeat at 4 weeks, repeat at 12 weeks, then every 3 months thereafter
Tirzepatide increases insulin sensitivity, adiponectin secretion and the lipidbuffering capacity of subcutaneous fat, thereby reducing ectopic lipid deposition in muscle, liver and myocardium and ameliorating systemic insulin resistance [13, 14]
Metabolic Regulation The combination of targeted receptor activity and prolonged action helps support appetite regulation and metabolic health
Weeks 1-4: 2.5mg once weekly
